BPC-157 for Tendon, Ligament, Muscle, Bone, and Nerve Recovery: What the Evidence Can and Cannot Show

BPC-157, often expanded as Body Protection Compound-157, is a peptide that has attracted interest because preclinical research has reported activity across several tissue types involved in repair. In injury-focused discussions, the most relevant areas are tendons, ligaments, skeletal muscle, bone, and peripheral nerves.

The central scientific question is not whether BPC-157 is a general performance enhancer or anabolic compound. The more specific question is whether it can influence biological conditions associated with healing, such as blood vessel formation, nitric oxide signaling, cell migration, collagen deposition, and growth-factor responsiveness.

BPC-157 is usually discussed as a multi-pathway repair compound rather than as a peptide with one dominant receptor target. That distinction matters because tendon, ligament, muscle, bone, and nerve recovery are not single-step processes. They require vascular response, inflammatory regulation, cell recruitment, extracellular matrix remodeling, and restoration of function over time.

One proposed mechanism involves nitric oxide regulation. Rather than simply acting like a nitric oxide booster, BPC-157 has been described as appearing to normalize nitric oxide signaling. Mechanistic discussions include eNOS, VEGFR2, and Src kinase pathways, all of which are relevant to vascular function and repair signaling.

Angiogenesis, the formation of new blood vessels, is a recurring theme in BPC-157 research discussions. VEGF-related signaling, capillary formation, improved blood supply, and nutrient delivery are all relevant to injured connective tissues. This is especially important for tendons, which often heal slowly in part because of limited vascularity.